BackgroundCheck.run
Search For

John C Chabala, 76Chatham Township, NJ

John Chabala Phones & Addresses

Chatham, NJ   

Westfield, NJ   

Studio City, CA   

Menlo Park, CA   

221 Throwbridge Dr, Scotch Plains, NJ 07076    908-6543679    908-6546071   

Mountainside, NJ   

Bristol, PA   

Union, NJ   

Cambridge, MA   

Work

Company: Merck & co inc 1990 Position: Supply clerk; kenilworth packaging operations

Education

School / High School: Linden High School- Linden, NJ 1975

Mentions for John C Chabala

John Chabala resumes & CV records

Resumes

John Chabala Photo 25

Chief Technical Analyst

Location:
San Francisco, CA
Industry:
Pharmaceuticals
Work:
Inclinica
Chief Technical Analyst
Oculogics Aug 2012 - May 2017
Vice President Chemistry
Pharmaceutical Consulting Aug 2012 - May 2017
Medicinal Chemistry Consultant
Pharmacopeia 1993 - 1997
President and Chief Scientific Officer
Bristol-Myers Squibb 1991 - 1993
Vice President Discovery Chemistry
Merck 1974 - 1991
Executive Director Basic Chemistry
Education:
Massachusetts Institute of Technology 1970 - 1975
Doctorates, Doctor of Philosophy, Organic Chemistry
Bucknell University 1968 - 1970
Bachelors, Bachelor of Science, Chemistry
Skills:
Pharmaceutical Industry, Medicinal Chemistry, Clinical Development, Hplc, Molecular Modeling, Adme, Lifesciences, Chemistry, Drug Development, Biomarker Discovery, Life Sciences, Biotechnology, Drug Discovery, In Vivo, Clinical Trials, Oncology, Start Ups, Strategy, Intellectual Property, Technology Transfer, Licensing, In Vitro, Pharmaceutics, Biopharmaceuticals
John Chabala Photo 26

Help Desk Technician

Work:
Continuum
Help Desk Technician
John Chabala Photo 27

John Chabala

Location:
United States
John Chabala Photo 28

John Chabala - Union Beach, NJ

Work:
Merck & Co Inc 1990 to 2011
Supply Clerk; Kenilworth Packaging Operations
American Flange & Manufacturing Company 1975 to 1990
Group Leader, New Jersey

Publications & IP owners

Us Patents

Methods And Compositions Utilizing Quinazolinones

US Patent:
6545004, Apr 8, 2003
Filed:
Oct 24, 2000
Appl. No.:
09/699047
Inventors:
Jeffrey T. Finer - Foster City CA
Gustave Bergnes - Pacifica CA
Whitney W. Smith - El Cerrito CA
John C. Chabala - Mountainside NJ
Bainian Feng - Foster City CA
Assignee:
Cytokinetics, Inc. - South San Francisco CA
International Classification:
A01N 4354
US Classification:
5142662, 5142663, 544284, 544287
Abstract:
Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.

Methods And Compositions Utilizing Quinazolinones

US Patent:
6562831, May 13, 2003
Filed:
Nov 28, 2000
Appl. No.:
09/724644
Inventors:
Jeffrey T. Finer - Foster City CA
Gustave Bergnes - Pacifica CA
Whitney W. Smith - El Cerrito CA
John C. Chabala - Mountainside NJ
Bainian Feng - Foster City CA
Assignee:
Cytokinetics, Inc. - South San Francisco CA
International Classification:
A61K 31517
US Classification:
5142663, 51426631, 436504, 544284, 544287
Abstract:
Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.

Methods And Compositions Utilizing Quinazolinones

US Patent:
6630479, Oct 7, 2003
Filed:
Nov 28, 2000
Appl. No.:
09/724713
Inventors:
Jeffrey T. Finer - Foster City CA
Gustave Bergnes - Pacifica CA
Whitney W. Smith - El Cerrito CA
John C. Chabala - Mountainside NJ
Bainian Feng - Foster City CA
Assignee:
Cytokinetics, Inc. - South San Francisco CA
International Classification:
A61K 3152
US Classification:
5142663, 5142662, 51426631, 544284, 544287, 544290
Abstract:
Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.

Methods And Compositions Utilizing Quinazolinones

US Patent:
6831085, Dec 14, 2004
Filed:
Nov 28, 2000
Appl. No.:
09/724941
Inventors:
Gustave Bergnes - Pacifica CA
Whitney W. Smith - El Cerrito CA
John C. Chabala - Mountainside NJ
Assignee:
Cytokinetics, Inc. - South San Francisco CA
International Classification:
A61K 31517
US Classification:
5142662, 5142663, 51426631, 544284, 544287
Abstract:
Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.

Phenothiazine Kinesin Inhibitors

US Patent:
6992082, Jan 31, 2006
Filed:
Jan 18, 2002
Appl. No.:
10/466735
Inventors:
Jeffrey T. Finer - Foster City CA, US
John C. Chabala - Mountainside NJ, US
Assignee:
Cytokinetics, Inc. - South San Francisco CA
International Classification:
A61K 31/5415
C07D 417/04
C07D 417/06
C07D 417/14
US Classification:
5142252, 544 42, 544 44, 544 46, 544 41, 5142255, 5142258
Abstract:
Phenothiazine derivatives of formula (I) are disclosed. The compounds are inhibitors of the mitotic kinesin KSP and are useful in the treatment of cellular proliferative diseases, such as cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation.

Methods And Compositions Utilizing Quinazolinones

US Patent:
7105668, Sep 12, 2006
Filed:
Nov 28, 2000
Appl. No.:
09/724897
Inventors:
Gustave Bergnes - Pacifica CA, US
Whitney W. Smith - El Cerrito CA, US
John C. Chabala - Mountainside NJ, US
Assignee:
Cytokinetics, Inc. - South San Francisco CA
International Classification:
C07D 239/90
US Classification:
544284, 544287
Abstract:
Quinazolinones of formulae 1, 1, 1and 1are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.

Phenothiazine Kinesin Inhibitors

US Patent:
7119089, Oct 10, 2006
Filed:
Sep 16, 2005
Appl. No.:
11/227286
Inventors:
Jeffrey T. Finer - Foster City CA, US
John C. Chabala - Mountainside NJ, US
Assignee:
Cytokinetics, Inc. - South San Francisco CA
International Classification:
A61K 31/5415
US Classification:
5142252, 5142255, 5142258
Abstract:
Phenothiazine derivatives of formula (I) are disclosed. The compounds are inhibitors of the mitotic kinesin KSP and are useful in the treatment of cellular proliferative diseases, such as cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation.

Methods And Compositions Utilizing Quinazolinones

US Patent:
7230000, Jun 12, 2007
Filed:
Nov 28, 2000
Appl. No.:
09/724778
Inventors:
Jeffrey T. Finer - Foster City CA, US
Gustave Bergnes - Pacifica CA, US
Whitney W. Smith - El Cerrito CA, US
John C. Chabala - Mountainside NJ, US
Bainian Feng - Foster City CA, US
Assignee:
Cytokinetics, Incorporated - South San Francisco CA
International Classification:
A61K 31/517
C07D 401/00
C07D 239/72
US Classification:
51426622, 51426623, 5142663, 544284, 544287
Abstract:
Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.